Search bioRxiv⌕ Search

Biology subjects

Goswami, V.

Publications and source records attributed to Goswami, V..

2 recordsLinked to original sources

Optimization of mRNA Synthesis and its Cell Expression for Vaccine Development

In vitro transcription (IVT) is a versatile procedure that facilitates template-directed synthesis of RNA molecules of any sequence, from short oligonucleotides to those of several kilobases, in quantities ranging from micrograms to milligrams. This technique, involving the engineering of a template with a bacteriophage promoter sequence, enables the synthesis of RNA for use in a variety of applications including structural studies, biochemical assays, and as functional molecules. Messenger RNA (mRNA) therapy has tremendous potential in regenerative medicine, disease treatment, and vaccination. Synthetic mRNA leverages the cells natural translation machinery to produce proteins, with the ability to transfect cells and induce expression of target proteins under physiological conditions until it is eventually degraded. In this study, we explore the impact of pseudouridine ({Psi})-modified mRNA in enhancing RNA stability, translational efficiency, and immune compatibility for therapeutic use. By optimizing IVT conditions and employing cellulose-based purification techniques, we successfully synthesized high-quality, modified mRNA that demonstrated superior functional performance. Luciferase and GFP mRNA, synthesized with pseudouridine-modified rNTPs, exhibited improved stability, reduced immune activation, and enhanced translation efficiency in HEK293 cells. A sevenfold increase in luciferase activity and elevated GFP fluorescence confirmed the higher protein expression capabilities of the modified mRNA. Furthermore, cellulose bead purification effectively separated single-stranded RNA from double-stranded RNA contaminants, ensuring minimal immune response and maximizing transfection efficiency. These findings highlight the potential of pseudouridine-modified mRNA and refined purification methods for advancing mRNA-based therapies, from vaccines to protein-replacement treatments, setting the foundation for scalable, clinical-grade RNA production.

cell biology↗

Prioritizing landscapes to reconcile biodiversity conservation, ecosystem services, and human well-being in India

Biodiversity conservation and human well-being are tightly interlinked; yet mismatches in the scale at which both priorities are planned and implemented have exacerbated biodiversity loss, erosion of ecosystem services, and declining human quality of life. India houses the second largest human population on the planet, while <5% of the countrys land area is effectively protected for conservation. This warrants landscape-level conservation planning through a judicious mix of land-sharing and land-sparing approaches, and co-production of ecosystem services. Through a multi-faceted assessment, we prioritize spatial extents of land parcels that, in the face of anthropogenic threats, can safeguard conservation landscapes across Indias biogeographic zones. We find that only a fraction (~15%) of such priority areas identified here are encompassed under Indias extant PA network, and several landscapes of high importance were omitted in all previous global-scale assessments. We then examined the spatial congruence of priority areas with administrative units earmarked for economic development by the Indian government, and propose management-zoning through state-driven and participatory approaches. Our spatially explicit insights can help meet the twin goals of biodiversity conservation and sustainable development in India and other countries across the Global South.

ecology↗